Evidence map›Paper›PMID 23535598›Full record

ArticleNature2013

Structural basis for the drug extrusion mechanism by a MATE multidrug transporter.

Yoshiki Tanaka, Christopher J Hipolito, Andrés D Maturana, Koichi Ito, Teruo Kuroda, Takashi Higuchi, Takayuki Katoh, Hideaki E Kato, Motoyuki Hattori, Kaoru Kumazaki and 4 more

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 257 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Structural insights into a citrate transporter that mediates aluminum tolerance in barley.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Structure of a lasso peptide bound ETNature communications · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Efflux pumps: gatekeepers of antibiotic resistance inMicrobial cell (Graz, Austria) · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Yoshiki TanakaRIKEN Advanced Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.
Christopher J Hipolito
Andrés D Maturana
Koichi Ito
Teruo Kuroda
Takashi Higuchi
Takayuki Katoh
Hideaki E Kato
Motoyuki Hattori
Kaoru Kumazaki
Tomoya Tsukazaki
Ryuichiro Ishitani
Hiroaki Suga
Osamu Nureki
The University of Tokyo · JPRIKEN Advanced Science Institute · JPJapan Science and Technology Agency · JPNagoya University · JPOkayama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug and toxic compound extrusion (MATE) family transporters are conserved in the three primary domains of life (Archaea, Bacteria and Eukarya), and export xenobiotics using an electrochemical gradient of H(+) or Na(+) across the membrane. MATE transporters confer multidrug resistance to bacterial pathogens and cancer cells, thus causing critical reductions in the therapeutic efficacies of antibiotics and anti-cancer drugs, respectively. Therefore, the development of MATE inhibitors has long been awaited in the field of clinical medicine. Here we present the crystal structures of the H(+)-driven MATE transporter from Pyrococcus furiosus in two distinct apo-form conformations, and in complexes with a derivative of the antibacterial drug norfloxacin and three in vitro selected thioether-macrocyclic peptides, at 2.1-3.0 Å resolutions. The structures, combined with functional analyses, show that the protonation of Asp 41 on the amino (N)-terminal lobe induces the bending of TM1, which in turn collapses the N-lobe cavity, thereby extruding the substrate drug to the extracellular space. Moreover, the macrocyclic peptides bind the central cleft in distinct manners, which correlate with their inhibitory activities. The strongest inhibitory peptide that occupies the N-lobe cavity may pave the way towards the development of efficient inhibitors against MATE transporters.

Indexed as

Amino Acid SequenceAntiportersApoproteinsArchaeal ProteinsAspartic AcidCrystallography, X-RayDNA Mutational AnalysisMacrocyclic CompoundsModels, MolecularMolecular Sequence DataNorfloxacinPeptidesProtein ConformationProtonsPyrococcus furiosusStructure-Activity RelationshipAntiportersApoproteinsArchaeal ProteinsAspartic AcidMacrocyclic CompoundsNorfloxacinPeptidesProtonsSulfides

Identifiers

PMID23535598
OpenAlexW2067800798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.